Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters
 

Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (116) clinical trials

Prospective, single arm, open-label, multicenter, post-market interventional clinical study to determine, via continuous monitoring with the Reveal XT implantable cardiac monitor (ICM), the incidence of atrial fibrillation (AF) in patients suspected to be at high risk for having AF and to understand how physicians manage these patients once AF has ...

Phase N/A

The Main Study will consist of a prospective, multi-center, randomized (1:1 concurrent nMARQ™ Catheter System [nMARQ] vs THERMOCOOL® Navigational Family of catheters [TC]), controlled, two-arm, single-blind design. Embedded within the Main Study will be a Subpopulation Neurological Assessment (SNA) with a prospective, controlled design, with consecutive enrollment. The objective of ...

Phase N/A

A Prospective, Randomized, Open-Label Blinded Endpont Evaluation (PROBE) Parallel Group Study Comparing Edoxaban (DU-176b) With Enoxaparin/Warfarin Followed by Warfarin Alone in subjects undergoing planned electrical Cardioversion of Nonvalvular Atrial Fibrillation

Phase N/A

To provide clinical data regarding the long-term safety and effectiveness of the Arctic Front® Cardiac Cryoablation Catheter System, including the Freezor® MAX Cardiac cryoablation catheter according to the Product Labeling. Demonstrate effectiveness (through 36 months) by assessing the rate of subjects free of chronic treatment failure with paroxysmal atrial fibrillation ...

Phase N/A

The purpose of this research study is to collect data on the clinical utility of the MediGuide system. This study does not require additional tests; all of the tests for this study are part of your normal care and would be done even if you were not in the study. ...

Phase N/A

To test the hypothesis that the treatment strategy of left atrial catheter ablation for the purpose of eliminating AF will be superior to current state-of-the-art medical therapy, with either rate control or rhythm control drugs for reducing total mortality Randomized: 1:1

Phase N/A

Heart failure (HF) is a major public health issue with a current prevalence of 2-3% in the total and 10-20% in the aged population (Lloyd-Jones et al., 2010). The overall prevalence for heart failure is increasing due to ageing population. Additional factors are the success of the modern therapies in ...

Phase N/A

Heart failure (HF) is a major threat to public health affecting 5.8 million individuals in the United States (U.S.). It is estimated that one in five people who have heart failure die within one year from diagnosis1. Several randomized clinical trials have demonstrated the benefits of heart failure patients receiving ...

Phase N/A

Numerous clinical studies have evaluated the benefits of biventricular pacing compared to optimal medical therapy1,2. However, some patients, who have undergone a successful implantation of a biventricular pacing device, do not have a measurable improvement in cardiac performance or symptoms3. Such patients are generally considered to be CRT non-responders. Clinical ...

Phase N/A